2024 MDA Clinical & Scientific Conference Keynote Speaker is Brooke Eby
Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference
15 févr. 2024 09h00 HE | Muscular Dystrophy Association
New York, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific...
22157.jpg
Europe Cell Penetrating Peptide Market Analysis Report 2023-2030: With the Advent of CRISPR-Cas9, there is a Growing Trend to Leverage CPPs for Intracellular Delivery of Gene-editing Tools
14 févr. 2024 11h43 HE | Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Europe Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By End-use, By Application (Drug Delivery, Gene Delivery, Diagnostics,...
Global Flow Cytometry in Oncology and Immunology Market
Flow Cytometry in Oncology and Immunology Market Set for Growth Amid Increasing Global Cancer Prevalence
24 janv. 2024 13h24 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry in Oncology and Immunology Market Report 2023" report has been added to ResearchAndMarkets.com's offering. As per the latest...
22157.jpg
Drug Development Online Course: Key to Success from Concept to Commercialization - Earn Up to 8 Credits Towards RAC Recertification Upon Full Completion
17 janv. 2024 10h33 HE | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Drug Development: Key to Success from Concept to Commercialization" training has been added to ResearchAndMarkets.com's offering.Join Top Drug...
New FDA Drug Approval for Duchenne Muscular Dystrophy
Muscular Dystrophy Association-Supported Drug AGAMREE® (vamorolone) Approved for the Treatment of Duchenne Muscular Dystrophy by the FDA
26 oct. 2023 16h24 HE | Muscular Dystrophy Association
New York, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of AGAMREE® (vamorolone), a structurally unique...
Global Protein Labeling Market
Global Protein Labeling Market Research Report 2023-2030: Diverse Applications Gaining Momentum - Protein Labeling Finds Key Roles in Biomedical Research
03 oct. 2023 10h23 HE | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Protein Labeling Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Method, By Application (Mass Spectrometry, Cell-based...
Global Flow Cytometry Market
Flow Cytometry Global Market Forecast to 2028: Clinical Applications of Flow Cytometry to Witness Significant Growth - Industry-Academia Collaborations Spur Market Expansion
14 sept. 2023 07h33 HE | Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research...
Logo.jpg
FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy in the Treatment of Renal Cell Carcinoma
31 juil. 2023 06h00 HE | Invectys, Inc.
Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies for advanced cancers, is pleased to announce the...
Global Biobanking Market
Global Biobanking Market Report 2023: Focus on Genetic Testing and Precision Medicine Drives Growth
31 mai 2023 10h13 HE | Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell Lines),...
researchdrivelogo.jpg
Global 3D Eye Tracking Software Market to Generate $1,778.4 Million by 2031 and Expected to Grow at a CAGR of 27.8% in the 2022-2031 Timeframe [250-Pages] | Details by Research Dive
25 avr. 2023 12h30 HE | Research Dive
New York, USA, April 25, 2023 (GLOBE NEWSWIRE) -- As per Research Dive’s latest report, the global 3D eye tracking software market is expected to garner a revenue of $1,778.4 million by 2031 and...